| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9549999 | GE HEALTHCARE | Radiopharmaceutical composition |
Mar, 2030
(6 years from now) | |
Myoview is owned by Ge Healthcare.
Myoview contains Technetium Tc-99M Tetrofosmin Kit.
Myoview has a total of 1 drug patent out of which 0 drug patents have expired.
Myoview was authorised for market use on 09 February, 1996.
Myoview is available in injectable;injection dosage forms.
The generics of Myoview are possible to be released after 10 March, 2030.
Drugs and Companies using TECHNETIUM TC-99M TETROFOSMIN KIT ingredient
Market Authorisation Date: 09 February, 1996
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
MYOVIEW family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic